BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9128287)

  • 1. Histologic, molecular, and radiologic characterization of resolving cerebral posttransplant lymphoproliferative disorder.
    Dean AF; Diss TC; Wotherspoon AC; Cox T; Nevard C
    Pediatr Res; 1997 May; 41(5):651-6. PubMed ID: 9128287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttransplant lymphoproliferative disorder with lung involvement in a renal transplant recipient.
    Mirza EI; Mutluay R; Suyani E; Okyay GU; Akyurek N; Aki SZ; Derici U; Arinsoy T
    Exp Clin Transplant; 2011 Dec; 9(6):425-8. PubMed ID: 22142053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.
    Heyny-von Haussen R; Klingel K; Riegel W; Kandolf R; Mall G
    Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttransplant lymphoproliferative disorder presenting as an isolated skin lesion.
    Gonthier DM; Hartman G; Holley JL
    Am J Kidney Dis; 1992 Jun; 19(6):600-3. PubMed ID: 1595711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant.
    Chadburn A; Chen JM; Hsu DT; Frizzera G; Cesarman E; Garrett TJ; Mears JG; Zangwill SD; Addonizio LJ; Michler RE; Knowles DM
    Cancer; 1998 May; 82(10):1978-87. PubMed ID: 9587133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapidly developing T-cell posttransplantation lymphoproliferative disorder.
    Kim JY; Kim CW; Ahn C; Bang YJ; Lee HS
    Am J Kidney Dis; 1999 Jul; 34(1):e3. PubMed ID: 10401041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis by polymerase chain reaction of ocular posttransplant lymphoproliferative disorder after pediatric renal transplantation.
    Al-Attar L; Berrocal A; Warman R; Dubovy S; Paredes A; Chan CC; Davis J
    Am J Ophthalmol; 2004 Mar; 137(3):569-71. PubMed ID: 15013889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Epstein-Barr virus DNA in sequential renal transplant biopsy specimens using the polymerase chain reaction. Report of a patient with a posttransplant lymphoproliferative disorder.
    Lager DJ; Slagel DD; Burgart LJ
    Arch Pathol Lab Med; 1993 Mar; 117(3):308-12. PubMed ID: 8382918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient.
    Yin CC; Medeiros LJ; Abruzzo LV; Jones D; Farhood AI; Thomazy VA
    Am J Clin Pathol; 2005 Feb; 123(2):222-8. PubMed ID: 15842046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
    Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
    Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
    Henry DD; Hunger SP; Braylan RC; Dharnidharka VR
    Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttransplantation lymphoproliferative disorder: changing manifestations of disease in a renal transplant population.
    Miller WT; Siegel SG; Montone KT
    Crit Rev Diagn Imaging; 1997 Dec; 38(6):569-85. PubMed ID: 9442979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [T-cell lymphoproliferative disorder involving the central nervous system in two cases].
    Inoha S; Inamura T; Ohga S; Hara T; Fukui M
    No Shinkei Geka; 2000 May; 28(5):435-9. PubMed ID: 10806627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttransplant lymphoproliferative disorder in an 11-year-old immunosuppressed boy.
    Nelson A; Dhamija R; Nickels K
    Pediatr Neurol; 2013 May; 48(5):397-9. PubMed ID: 23583059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients. Clonal analysis based on immunoglobulin-gene rearrangements.
    Cleary ML; Warnke R; Sklar J
    N Engl J Med; 1984 Feb; 310(8):477-82. PubMed ID: 6363929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
    Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
    Srivastava T; Zwick DL; Rothberg PG; Warady BA
    Pediatr Nephrol; 1999 Nov; 13(9):748-54. PubMed ID: 10603113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated cerebral post-transplant lymphoproliferative disorder in a lymphoma recipient.
    Tang TC; Chuang WY; Chang H
    J Cancer Res Ther; 2013; 9(3):534-6. PubMed ID: 24126003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.
    Fischer A; Blanche S; Le Bidois J; Bordigoni P; Garnier JL; Niaudet P; Morinet F; Le Deist F; Fischer AM; Griscelli C
    N Engl J Med; 1991 May; 324(21):1451-6. PubMed ID: 2023604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined fine needle aspiration biopsy, and immunophenotypic and genotypic approach to posttransplantation lymphoproliferative disorders.
    Collins BT; Ramos RR; Grosso LE
    Acta Cytol; 1998; 42(4):869-74. PubMed ID: 9684570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.